TD Asset Management’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-13,441
Closed -$305K 1458
2022
Q4
$305K Hold
13,441
﹤0.01% 1356
2022
Q3
$335K Hold
13,441
﹤0.01% 1357
2022
Q2
$332K Sell
13,441
-7,159
-35% -$179K ﹤0.01% 1345
2022
Q1
$684K Hold
20,600
﹤0.01% 1302
2021
Q4
$674K Hold
20,600
﹤0.01% 1348
2021
Q3
$864K Buy
20,600
+435
+2% +$15.7K ﹤0.01% 1287
2021
Q2
$652K Hold
20,165
﹤0.01% 1354
2021
Q1
$688K Buy
20,165
+1,645
+9% +$70.2K ﹤0.01% 1340
2020
Q4
$840K Hold
18,520
﹤0.01% 1221
2020
Q3
$510K Hold
18,520
﹤0.01% 1235
2020
Q2
$682K Hold
18,520
﹤0.01% 1152
2020
Q1
$600K Sell
18,520
-4,700
-20% -$196K ﹤0.01% 1129
2019
Q4
$951K Sell
23,220
-3,000
-11% -$119K ﹤0.01% 1107
2019
Q3
$933K Sell
26,220
-7,600
-22% -$308K ﹤0.01% 1069
2019
Q2
$1.74M Sell
33,820
-1,500
-4% -$74.9K ﹤0.01% 938
2019
Q1
$2.02M Buy
35,320
+13,900
+65% +$689K ﹤0.01% 900
2018
Q4
$899K Buy
21,420
+5,220
+32% +$306K ﹤0.01% 1083
2018
Q3
$1.22M Buy
16,200
+2,600
+19% +$187K ﹤0.01% 1116
2018
Q2
$976K Buy
13,600
+2,700
+25% +$129K ﹤0.01% 1134
2018
Q1
$325K Buy
10,900
+200
+2% +$5.82K ﹤0.01% 1269
2017
Q4
$356K Buy
+10,700
New +$322K ﹤0.01% 1241
2017
Q1
Sell
-17,866
Closed -$331K 1416
2016
Q4
$331K Sell
17,866
-4,899
-22% -$93.6K ﹤0.01% 1280
2016
Q3
$319K Sell
22,765
-400
-2% -$4.41K ﹤0.01% 1286
2016
Q2
$185K Hold
23,165
﹤0.01% 1333
2016
Q1
$250K Buy
+23,165
New +$296K ﹤0.01% 1272

Other funds holding RGNX